Does Ansuvimab Interact with Live Vaccines?
Ansuvimab and Live Vaccines have a moderate drug interaction according to U.S. FDA drug labeling data. EBANGA may reduce the efficacy of live vaccine for Orthoebolavirus zairense. Avoid concurrent administration during treatment; time administration per vaccination guidelines. The mechanism involves ebanga may inhibit replication of live vaccine virus. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Ansuvimab Class
- Zaire Ebolavirus Glycoprotein-directed Antibody
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Ansuvimab and Live Vaccines occurs because ebanga may inhibit replication of live vaccine virus. Clinically, this means ebanga may reduce the efficacy of live vaccine for orthoebolavirus zairense. avoid concurrent administration during treatment; time administration per vaccination guidelines. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Ansuvimab and your doctor is considering prescribing Live Vaccines (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider